Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:57:23.974Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:57:23.974Z.
Quote observation: 2026-10-06T15:54:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f372f39edc86e990c580289f142e0fc1828f45467bffd466be8591b91f734aee
FORWARD PE RATIO
N/A
NOMAD Power Solutions, Inc.
Market Cap
$52.64M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| NOMAD Power Solutions, Inc. (NMAD) | $52.64M | N/A |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $52.46M | N/A |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.54M | N/A |
| ImageneBio Inc (IMA)vs › | $53.80M | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $51.36M | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.34M | N/A |
| INmune Bio, Inc. (INMB)vs › | $51.18M | N/A |
| Clene Inc. (CLNN)vs › | $51.09M | N/A |
| Microbot Medical Inc. (MBOT)vs › | $50.81M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
